Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis

Epidemiological Study About the Clinical and Microbiological Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis.

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02248506

Enrollment

Registered

2014-09-25

Start date

2013-06-30

Completion date

2015-03-31

Last updated

2015-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Candidiasis, Vulvovaginal

Keywords

Candidiasis

Brief summary

To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis.

Interventions

OTHERClotrimazole

All patients receive standard antifungal treatment for this type of infections consisting Clotrimazole 500 Single dose (standard treatment).

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 50 Years

Healthy volunteers

Yes

Inclusion criteria

* Sexually active women between 18 and 50 years * Patients attending to the gynecologist with acute vulvovaginal candidiasis. * Patients requiring standard treatment with clotrimazole 500 single dose and that the decision to prescribe this treatment is prior to inclusion in the study. * Women who agree to participate in the study and has signed the informed consent sheet.

Exclusion criteria

* Use of any medication that may interfere significantly with study assessments. * Pregnant or breastfeeding * Women with signs of other genital infection * Within 3 months after childbirth or abortion * Patients that is expected not to attend follow-up visits

Design outcomes

Primary

Measure	Time frame	Description
Vaginal swab test	Baseline	To verify diagnosis of vaginal candidiasis

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026